Arbutus, Genevant reject Moderna’s vaccine patent defence
07-06-2022
Afrigen creates COVID vaccine using Moderna data
15-02-2022
Moderna in dispute with US govt over COVID-19 vaccine inventors
11-11-2021
guteksk7 / Shutterstock.com
Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Moderna, government, vaccine, COVID-19, biopharma, infringement, lawsuit, Arbutus, Genevant, biotech, statute, federal, claims, patent, immunity
